Molly A. McCord, PharmD, describes pediatric-specific differences in pharmacokinetics as it applies to commonly used immunosuppressants, discusses concerns related to medication formulations, monitoring, and adherence in the pediatric population, reviews pediatric solid organ transplantation pharmacotherapeutic controversies in immunosuppression and infection prevention. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Molly A. McCord, PharmD, describes pediatric-specific differences in pharmacokinetics as it applies to commonly used immunosuppressants, discusses concerns related to medication formulations, monitoring, and adherence in the pediatric population, reviews pediatric solid organ transplantation pharmacotherapeutic controversies in immunosuppression and infection prevention. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Think of the Children! Pediatric Solid Organ Transplantation

Mackenzie L. Bevry, PharmD, identifies the key populations that currently have evidence for improved outcomes with pre-emptive pharmacogenomic testing, describes the difference between clinical and direct-to-consumer pharmacogenomic testing, recognizes some of the currently available pharmacogenomic testing options available to patients. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Mackenzie L. Bevry, PharmD, identifies the key populations that currently have evidence for improved outcomes with pre-emptive pharmacogenomic testing, describes the difference between clinical and direct-to-consumer pharmacogenomic testing, recognizes some of the currently available pharmacogenomic testing options available to patients. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Being Prepared for Questions on Direct-To-Consumer Preemptive Pharmacogenomic Testing

Michaela E. Wermers, PharmD, defines therapeutic options and appropriate dosing methods for oral iron replacement, identifies the various intravenous iron therapies and discuss product differences, reviews literature of select disease states in which intravenous iron therapy is utilized. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Michaela E. Wermers, PharmD, defines therapeutic options and appropriate dosing methods for oral iron replacement, identifies the various intravenous iron therapies and discuss product differences, reviews literature of select disease states in which intravenous iron therapy is utilized. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Ironing Out the Details: A Thorough Review of Iron Therapies

Stacy A. Bernard, PharmD, BCPS, BCTXP, reviews anti-hypertensive agents and their use in the longitudinal care of a solid organ transplant patient, relates drug-drug interactions between statins and immunosuppressive therapies to dyslipidemia treatment decisions in a solid organ transplant patient, discusses short- and long-term considerations when selecting an anticoagulation regimen for a solid organ transplant patient. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Stacy A. Bernard, PharmD, BCPS, BCTXP, reviews anti-hypertensive agents and their use in the longitudinal care of a solid organ transplant patient, relates drug-drug interactions between statins and immunosuppressive therapies to dyslipidemia treatment decisions in a solid organ transplant patient, discusses short- and long-term considerations when selecting an anticoagulation regimen for a solid organ transplant patient. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Breadth of Care: Heart Health after Organ Transplantation

Marissa Z. Powell, PharmD, describes mechanisms of chronic graft versus host disease, recognizes historical approaches to treatment of chronic graft versus host disease, discusses recent updates in chronic graft versus host disease therapy. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Marissa Z. Powell, PharmD, describes mechanisms of chronic graft versus host disease, recognizes historical approaches to treatment of chronic graft versus host disease, discusses recent updates in chronic graft versus host disease therapy. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

ROCKing the Chronic GVHD Boat: Updates in the Treatment of Chronic Graft versus Host Disease

Hosted by Garrett E. Schramm, Pharm.D., Mayo Clinic Pharmacy Grand Rounds is a weekly podcast for pharmacists, physicians, physician assistants, and nurse practitioners who are interested in learning more about clinical pharmacology topics. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Hosted by Garrett E. Schramm, Pharm.D., Mayo Clinic Pharmacy Grand Rounds is a weekly podcast for pharmacists, physicians, physician assistants, and nurse practitioners who are interested in learning more about clinical pharmacology topics. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Keep It Spicy – Capsaicin for Treatment of Cannabis Hyperemesis Syndrome

Danielle M. Hess, PharmD, BCPS, describes the mechanism of action of ketamine as it relates to chronic pain relief, evaluates literature depicting the role of ketamine for chronic pain management, and defines patient scenarios and/or conditions in which guidelines recommend the potential use and safety precautions of ketamine for chronic pain. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Danielle M. Hess, PharmD, BCPS, describes the mechanism of action of ketamine as it relates to chronic pain relief, evaluates literature depicting the role of ketamine for chronic pain management, and defines patient scenarios and/or conditions in which guidelines recommend the potential use and safety precautions of ketamine for chronic pain. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

How Special is Ketamine? Examining the Evidence for Chronic Pain Management

Cassandra J. Schmitt, PharmD, determines risk factors associated with severe COVID-19 disease progression, discusses efficacy and safety outcomes of novel agents for the outpatient treatment of COVID-19, identifies the ideal candidate to receive treatment with oral molnupiravir, nirmatrelvir/ritonavir, or intravenous monoclonal antibodies for mild-to-moderate COVID-19. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Cassandra J. Schmitt, PharmD, determines risk factors associated with severe COVID-19 disease progression, discusses efficacy and safety outcomes of novel agents for the outpatient treatment of COVID-19, identifies the ideal candidate to receive treatment with oral molnupiravir, nirmatrelvir/ritonavir, or intravenous monoclonal antibodies for mild-to-moderate COVID-19. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Mad for mAbs and Oral Outpatient COVID-19 Treatments

Jia Yin Townley, PharmD, BCPS, describes the pathophysiology of short bowel syndrome, identifies the medications used to manage short bowel syndrome and recognizes ways to optimize medication regimens for short bowel syndrome patients. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Jia Yin Townley, PharmD, BCPS, describes the pathophysiology of short bowel syndrome, identifies the medications used to manage short bowel syndrome and recognizes ways to optimize medication regimens for short bowel syndrome patients. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Short But Sweet: Medication Considerations in Short Bowel Syndrome

Sydney E. Schultz, PharmD, @SydneyPharmD identifies presentation, prognostic factors and pathology associated with cancer of unknown primary, reviews historical treatment approaches, and discusses the role for use of molecular profiling to guide treatment.  Twitter: @SydneyPharmD For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Sydney E. Schultz, PharmD, @SydneyPharmD identifies presentation, prognostic factors and pathology associated with cancer of unknown primary, reviews historical treatment approaches, and discusses the role for use of molecular profiling to guide treatment.  Twitter: <a href="https://twitter.com/sydneypharmd" rel="nofollow" target="_blank">@SydneyPharmD</a> For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

What’s Up with CUP?

A weekly podcast for pharmacists, physicians, physician assistants, and nurse practitioners who are interested in learning more about clinical pharmacology topics. To claim pharmacology CE credit or to get a copy of presentation slides, visit https://ce.mayo.edu/pharmacypodcast. Produced by @MayoMedEd. Hosted by @garrett_schramm.

Joseph C. Osborne II, PharmD, @JOzempic describes the pharmacology of aducanumab, summarizes the clinical literature and approval process for aducanumab, and discusses stewardship considerations of aducanumab.  Twitter: @JOzempic For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Joseph C. Osborne II, PharmD, @JOzempic describes the pharmacology of aducanumab, summarizes the clinical literature and approval process for aducanumab, and discusses stewardship considerations of aducanumab.  Twitter: <a href="https://mobile.twitter.com/jozempic" rel="nofollow" target="_blank">@JOzempic</a> For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Life in the Fast Lane: Aducanumab and the Accelerated FDA Approval Process

Megan L. Grochowski, PharmD, reviews the incidence of common Crotalidae snake envenomation in the United States, describes the progression of signs and symptoms associated with snakebites, explains the role, use, and administration of antivenom in snakebites, and reviews other interventional therapies utilized in the management and stabilization of snakebites. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Megan L. Grochowski, PharmD, reviews the incidence of common Crotalidae snake envenomation in the United States, describes the progression of signs and symptoms associated with snakebites, explains the role, use, and administration of antivenom in snakebites, and reviews other interventional therapies utilized in the management and stabilization of snakebites. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Don’t Be Sad, Be Fab! The Use of Antivenom for Management and Stabilization of Crotalidae Snakebites

Patrick M. Wieruszewski, PharmD, BCCCP, describes the mechanisms of the renin-angiotensin system and its interplay in vasodilatory shock, reviews emerging data surrounding the use of angiotensin II in vasodilatory shock and identifies clinical shock scenarios where angiotensin II may be of most benefit.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Patrick M. Wieruszewski, PharmD, BCCCP, describes the mechanisms of the renin-angiotensin system and its interplay in vasodilatory shock, reviews emerging data surrounding the use of angiotensin II in vasodilatory shock and identifies clinical shock scenarios where angiotensin II may be of most benefit.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Renin-Angiotensin System: Should We Give It More Attention in Shock?

Mohammad B. Najib, Pharm.D., BCPS, describes the pathophysiology of Neuroleptic Malignant Syndrome (NMS), lists risk factors involved in the disease process, identifies the diagnostic criteria and an overview of the signs and symptoms, and examines management and treatment options.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Mohammad B. Najib, Pharm.D., BCPS, describes the pathophysiology of Neuroleptic Malignant Syndrome (NMS), lists risk factors involved in the disease process, identifies the diagnostic criteria and an overview of the signs and symptoms, and examines management and treatment options.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

NMS What A Mess!

Rachel J. Johnson, Pharm.D., recalls common symptoms of Guillain-Barré Syndrome, describes the association between COVID-19 vaccines and Guillain-Barré Syndrome, and identifies appropriate treatment for a patient with Guillain-Barré Syndrome. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Rachel J. Johnson, Pharm.D., recalls common symptoms of Guillain-Barré Syndrome, describes the association between COVID-19 vaccines and Guillain-Barré Syndrome, and identifies appropriate treatment for a patient with Guillain-Barré Syndrome. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Management of Guillain-Barré Syndrome

Aeryana N. Beaudrie-Nunn, Pharm.D. (@ABeaudrieRx), identifies the rationale for immunodulatory therapy in COVID-19, explores clinical trial data regarding the use of Baricitinib in hospitalized patients with COVID-19, and defines the patient context where Baricitinib use is most appropriate.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Aeryana N. Beaudrie-Nunn, Pharm.D. (<a href="https://twitter.com/ABeaudrieRx" rel="nofollow" target="_blank">@ABeaudrieRx</a>), identifies the rationale for immunodulatory therapy in COVID-19, explores clinical trial data regarding the use of Baricitinib in hospitalized patients with COVID-19, and defines the patient context where Baricitinib use is most appropriate.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Overcoming the COV-BARRIER: The Role of Baricitinib in SARS-CoV-2

Andrew J. Jatis, Pharm.D. (@jatis_rx), recognizes the clinical heterogeneity of cardiogenic shock and its impact on clinical outcomes, describes current literature assessing vasopressors and inotropes in the management of cardiogenic shock, and determines an optimal pharmacologic regimen for the treatment of cardiogenic shock given individual patient characteristics.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Andrew J. Jatis, Pharm.D. (<a href="https://twitter.com/jatis_rx" rel="nofollow" target="_blank">@jatis_rx</a>), recognizes the clinical heterogeneity of cardiogenic shock and its impact on clinical outcomes, describes current literature assessing vasopressors and inotropes in the management of cardiogenic shock, and determines an optimal pharmacologic regimen for the treatment of cardiogenic shock given individual patient characteristics.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Shocking Updates in the Management of Cardiogenic Shock

Jennifer M. Nelson, Pharm.D., outlines Center for Disease Control and Prevention (CDC) guidelines for initial care of refugee populations, recognizes unique disease states, genetics, and cultural considerations for the Afghan refugee population, and identifies treatment for unique disease states in the Afghan refugee population.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Jennifer M. Nelson, Pharm.D., outlines Center for Disease Control and Prevention (CDC) guidelines for initial care of refugee populations, recognizes unique disease states, genetics, and cultural considerations for the Afghan refugee population, and identifies treatment for unique disease states in the Afghan refugee population.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

The Migration Medication Situation: Pharmacotherapy Consideration in Refugee Populations

Robert J. Schroeder, Pharm.D., explains the pharmacological principles of sacubitril/valsartan, recognizes the evidence favoring sacubitril/valsartan in heart failure and describes how to initiate sacubitril/valsartan.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Robert J. Schroeder, Pharm.D., explains the pharmacological principles of sacubitril/valsartan, recognizes the evidence favoring sacubitril/valsartan in heart failure and describes how to initiate sacubitril/valsartan.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Sacubitril/Valsartan: Heart Failure’s Worst Nightmare

Katelyn (Kate) R. Neverman, Pharm.D., identifies three continuous glucose monitors (CGMs) approved by the FDA, describes the difference between glucose management indicator (GMI) and hemoglobin A1c and discusses how to interpret glycemic data using an Ambulatory Glycemic Profile (AGP) report.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Katelyn (Kate) R. Neverman, Pharm.D., identifies three continuous glucose monitors (CGMs) approved by the FDA, describes the difference between glucose management indicator (GMI) and hemoglobin A1c and discusses how to interpret glycemic data using an Ambulatory Glycemic Profile (AGP) report.  For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href="https://twitter.com/MayoPharmRes" rel="nofollow" target="_blank">@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href="https://twitter.com/garrett_schramm" rel="nofollow" target="_blank">@garrett_schramm</a> on Twitter! You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href="https://ce.mayo.edu/" rel="nofollow" target="_blank">https://ce.mayo.edu/</a> or on Twitter <a href="https://twitter.com/MayoMedEd" rel="nofollow" target="_blank">@MayoMedEd</a>.

Continuous Glucose Monitors & GMI: Is this TMI?

A weekly podcast for pharmacists, physicians, physician assistants, and nurse practitioners who are interested in learning more about clinical pharmacology topics. To claim pharmacology CE credit or to get a copy of presentation slides, visit <a href="https://ce.mayo.edu/pharmacypodcast" rel="nofollow" target="_blank">https://ce.mayo.edu/pharmacypodcast</a>. Produced by @MayoMedEd. Hosted by @garrett_schramm.

Mayo Clinic Pharmacy Grand Rounds

The best podcast episodes on global issues affecting everyone. Covering topics such as the #metoo movement, climate change, the impact of technology and some of the biggest global issues facing us right now. For anyone interested in learning more about the world, and some of the issues we're facing, pick an episode below and start listening! Add episodes you're interested into your queue below!

Best Episodes on Global Issues

The Best Multi-Part Documentaries, with documentaries on Obama, Federer vs Nadal, the making of Star Wars, Netflix vs Blockbuster and more. Add episodes you're interested into your queue below!